Skip to main content
9LABS logo

9LABS

Security and trust center evidence

9LABS creates cutting-edge SaaS applications for pharmaceutical and biotech

Summary

9LABS has , and 1 expired in the CertReports index, last verified 2 Nov 2026. The strongest row is EU-US Data Privacy Framework: Inactive. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

As of 2 Nov 2026, CertReports holds 1 expired row for 9LABS, drawn from the Data Privacy Framework list. 9LABS previously appeared with EU-US Data Privacy Framework evidence, but the listing is no longer active and CertReports found no renewal as of 2 Nov 2026. No public evidence was found for SOC 2, ISO/IEC 27001, HIPAA and GDPR as of 2 Nov 2026; that is a gap in the public record, not a finding of non-coverage, and the vendor can supply it under NDA.

  • EU-US Data Privacy Framework: Inactive, expired as of 2 Nov 2026

Facts only, each dated; nothing here is inferred, scored or advised.

Among life sciences and biotech vendors

0verified rows

Category median 0, across 35 indexed life sciences and biotech vendors. 9LABS has no registry-verified row yet, like 54 percent of them; its evidence is vendor-stated or reported.

biotech softwareclinical softwarepharma softwaresaas platform

Compliance grid

No public evidence yet for HIPAA, SOC 2, GDPR, FedRAMP, PCI DSS, ISO 27001, CSA STAR, Cyber Essentials, ISO 27701, ISO 42001. This does not mean the vendor lacks them; it means nothing public was found at the last check.

Subprocessors

No subprocessor list captured yet.

Change history

  1. 18 Sep 2026First indexed by CertReports1 evidence row across 1 framework entered the index.

Similar vendors with evidence

Related by product tags and the Life sciences and biotech category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.

Evidence against regulations

All regulations for 9LABS

How much of each regulation’s vendor requirements 9LABS’s public evidence reaches.

All articles